AZN.L - AstraZeneca PLC

LSE - LSE Delayed Price. Currency in GBp
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in USD. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue22,090,00022,465,00023,002,00024,708,000
Cost of Revenue4,504,0004,137,0003,996,0004,488,000
Gross Profit17,586,00018,328,00019,006,00020,220,000
Operating Expenses
Research Development5,299,0005,455,0005,679,0005,660,000
Selling General and Administrative10,803,0009,505,0009,902,00011,024,000
Non Recurring----
Others-266,000-219,000-322,000-535,000
Total Operating Expenses20,340,00018,878,00019,255,00020,637,000
Operating Income or Loss1,750,0003,587,0003,747,0004,071,000
Income from Continuing Operations
Total Other Income/Expenses Net243,000-1,360,000-195,000-1,002,000
Earnings Before Interest and Taxes1,750,0003,587,0003,747,0004,071,000
Interest Expense-744,000-664,000-617,000-392,000
Income Before Tax1,993,0002,227,0003,552,0003,069,000
Income Tax Expense-57,000-641,000146,000243,000
Minority Interest1,576,0001,682,0001,815,00019,000
Net Income From Continuing Ops2,050,0002,868,0003,406,0002,826,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income2,155,0003,001,0003,499,0002,825,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares2,155,0003,001,0003,499,0002,825,000